Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  ResApp Health Limited    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 11/26
0.09 AUD   -1.10%
04/05RESAPP HEALTH : Morgans rates RAP as Add
AQ
2019RESAPP HEALTH : 2019 Letter to Shareholders
PU
2017RESAPP HEALTH : Updated Corporate Governance Policies
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at AUD 0.07 AUD in weekly data.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the AUD 0.08 support.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses

No significant weakness

Sector Enterprise Software
1st jan.Capitalisation (M$)Investor Rating
RESAPP HEALTH LIMITED-63.27%52
-
FAIR ISAAC CORPORATION26.93%13 779
SOLARWINDS CORPORATION23.61%7 201
Q2 HOLDINGS, INC.41.96%6 202
THE DESCARTES SYSTEMS GROUP..36.50%4 931
KINAXIS INC.88.06%3 906
DOUZONE BIZON CO., LTD.25.31%2 713
UPLAND SOFTWARE, INC.27.47%1 341
EBIX, INC.6.08%1 097
BEIJING EGOVA CO,. LTD7.02%892
FINEOS CORPORATION HOLDINGS..47.92%874
CHANNELADVISOR CORPORATION63.05%427
EGAIN CORPORATION48.74%364
HUMANICA PUBLIC COMPANY LIM..15.58%201
TXT E-SOLUTIONS S.P.A.-22.57%105
LOOPUP GROUP PLC9.09%58
More Results
Financials
Sales 2021 2,40 M 1,77 M 1,77 M
Net income 2021 -4,90 M -3,62 M -3,62 M
Net cash 2021 3,10 M 2,29 M 2,29 M
P/E ratio 2021 -15,3x
Yield 2021 -
Capitalization 69,7 M 51,6 M 51,5 M
EV / Sales 2021 27,8x
EV / Sales 2022 5,53x
Nbr of Employees -
Free-Float 85,9%
Upcoming event on RESAPP HEALTH LIMITED
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality
Business Predictability -
P/E ratio -
Potential
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision -
1 year Revenue revision -
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes